Hasil Pencarian - Baoyue Pan

  • Menampilkan 1 - 7 hasil dari 7
Perbaiki Hasil
  1. 1
    Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB

    Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB oleh Pingping Liu, Yinan Jiang, Xiaojing Zheng, Baoyue Pan, Huiling Xiang, Min Zheng

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    A Nomogram for Preoperative Prediction of the Risk of Lymph Node Metastasis in Patients with Epithelial Ovarian Cancer

    A Nomogram for Preoperative Prediction of the Risk of Lymph Node Metastasis in Patients with Epithelial Ovarian Cancer oleh Huiling Xiang, Fan Yang, Xiaojing Zheng, Baoyue Pan, Mingxiu Ju, Shijie Xu, Min Zheng

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Impact of the initial site of metastases on post-recurrence survival for neuroendocrine cervical cancer

    Impact of the initial site of metastases on post-recurrence survival for neuroendocrine cervical cancer oleh Baoyue Pan, Ting Wan, Yinan Jiang, Xiaojing Zheng, Pingping Liu, Huiling Xiang, Min Zheng

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkers

    Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkers oleh Xiaojing Zheng, Haifeng Gu, Xinping Cao, Baoyue Pan, Huiling Xiang, Mingxiu Ju, Shijie Xu, Min Zheng

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    The efficacy of first and second immunotherapy exposure in patients with recurrent or metastatic cervical cancer

    The efficacy of first and second immunotherapy exposure in patients with recurrent or metastatic cervical cancer oleh Mingxiu Ju, Baoyue Pan, Yongwen Huang, Yun Zhou, Jieping Chen, Huiling Xiang, Shije Xu, Siyu Chen, Chunyan Lan, Jundong Li, Min Zheng

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    The MYBL2–CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages

    The MYBL2–CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages oleh Baoyue Pan, Ting Wan, Yun Zhou, Shuting Huang, Linjing Yuan, Yinan Jiang, Xiaojing Zheng, Pingping Liu, Huiling Xiang, Mingxiu Ju, Rongzhen Luo, Weihua Jia, ChunYan Lan, Jundong Li, Min Zheng

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Targeting the Cdc2‐like kinase 2 for overcoming platinum resistance in ovarian cancer

    Targeting the Cdc2‐like kinase 2 for overcoming platinum resistance in ovarian cancer oleh Yinan Jiang, Shuting Huang, Lan Zhang, Yun Zhou, Wei Zhang, Ting Wan, Haifeng Gu, Yi Ouyang, Xiaojing Zheng, Pingping Liu, Baoyue Pan, Huiling Xiang, Mingxiu Ju, Rongzhen Luo, Weihua Jia, Shenjiao Huang, Jundong Li, Min Zheng

    Diterbitkan 2024-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: